As shown in Fig. S4A, B, mice that received the PLK1122DC_TriVax with PD-L1 blockade had comparably higher numbers of antigen-specific CD8 T-cells capable of effectively recognising C1498 tumour cells, whereas mice that received the Ova55DC_TriVax did not have any detectable PLK1122-specific CD8 T-cell responses. The gene discussed is CD8A; the disease is neoplasm.